Labcorp Confirms NYSE Listing for Common Stock (LH)

TL;DR

**Labcorp just filed an 8-K confirming its common stock is still listed on the NYSE under LH.**

AI Summary

Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on January 11, 2024, to disclose that its Common Stock, with a $0.10 par value, is registered on the New York Stock Exchange under the trading symbol 'LH'. This filing primarily serves to update its registration status and confirm its compliance with SEC regulations. For investors, this matters because it reaffirms the company's continued listing on a major exchange, ensuring liquidity and transparency for its shares.

Why It Matters

This filing confirms Labcorp's continued compliance with exchange listing requirements, which is crucial for maintaining investor confidence and the liquidity of its shares.

Risk Assessment

Risk Level: low — This filing is purely administrative, confirming existing information, and does not introduce new financial or operational risks.

Analyst Insight

This filing is administrative and confirms existing information, so no immediate action is required for investors. It simply reaffirms the company's compliance and market presence.

Key Numbers

• $0.10 — par value per share (the stated par value of Labcorp's Common Stock)

Key Players & Entities

• LABORATORY CORPORATION OF AMERICA HOLDINGS (company) — the registrant filing the 8-K
• New York Stock Exchange (company) — the exchange where Labcorp's stock is registered
• $0.10 (dollar_amount) — par value of the Common Stock
• LH (company) — trading symbol for Labcorp's Common Stock
• January 11, 2024 (date) — date of earliest event reported

Forward-Looking Statements

• Labcorp will continue to maintain its listing on the New York Stock Exchange. (LABORATORY CORPORATION OF AMERICA HOLDINGS) — high confidence, target: 2025-01-11

FAQ

Key Financial Figures

• $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
• $0.72 — clared a cash dividend in the amount of $0.72 per share of common stock, to be paid o

Filing Documents

• lh-20240111.htm (8-K) — 25KB
• formpr11224ex991dividendan.htm (EX-99.1) — 4KB
• lc2020logov2.gif (GRAPHIC) — 5KB
• 0000920148-24-000004.txt ( ) — 161KB
• lh-20240111.xsd (EX-101.SCH) — 2KB
• lh-20240111_lab.xml (EX-101.LAB) — 24KB
• lh-20240111_pre.xml (EX-101.PRE) — 12KB
• lh-20240111_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure On January 12, 2024, Laboratory Corporation of America Holdings announced that its Board of Directors has declared a cash dividend in the amount of $0.72 per share of common stock, to be paid on March 13, 2024, to the holders of record of all of the issued and outstanding shares of common stock as of the close of business on February 27, 2024. A copy of the press release announcing the dividend is furnished as Exhibit 99.1 hereto and incorporated by reference herein.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated January 12, 2024 issued by Labcorp Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary January 12, 2024

View Full Filing

View this 8-K filing on SEC EDGAR